0407-1411 : Omnipaque 388.3 mg/ml Intravenous Injection


NDC0407-1411
Labeler: Ge Healthcare Inc.
Product Type: Human Prescription Drug
Drug Name:  Omnipaque
Dosage Form: Intravenous Injection
Application #: NDA018956
Rev. Date: 


NDC Package Codes:

  • 0407-1411-10: 10 VIAL, GLASS IN 1 BOX (0407‑1411‑10) > 10 ML IN 1 VIAL, GLASS
  • 0407-1411-20: 10 VIAL, GLASS IN 1 BOX (0407‑1411‑20) > 20 ML IN 1 VIAL, GLASS

Active Ingredients:

  • Iohexol

Dosage Strength:

  • 180 mg/mL

Pharmaceutical Classes:

  • Radiographic Contrast Agent [EPC]
  • X-Ray Contrast Activity [MoA]

Related Products:

Based on records with the same trade name.
  • 0407-1401 Omnipaque 302 mg/ml Intravenous Injection by Ge Healthcare Inc.
  • 0407-1412 Omnipaque 518 mg/ml Intrathecal; Intravascular; Intravenous; Oral Injection by Ge Healthcare Inc.
  • 0407-1413 Omnipaque 647 mg/ml Intravenous Injection by Ge Healthcare Inc.
  • 0407-1414 Omnipaque 755 mg/ml Intravenous Injection by Ge Healthcare Inc.
  • 0407-1415 Omnipaque 9 mg/ml Oral Solution by Ge Healthcare Inc.
  • 0407-1416 Omnipaque 12 mg/ml Oral Solution by Ge Healthcare Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0407-1411 QR Code

< Prev: 0407-1401Next: 0407-1412 >

Related Discussions:

Omnipaque and Movicol causing a rash on my face and neck
I had a virtual Colonoscopy for which I had to drink three 50ml bottles of Omnipaque 350 with 2 sachets of Movicol the d...
Side Effects With Omnipaque
Dx: prostate cancer getting CT of abd/pelvis, need to take omnipaque as oral prep what side effects should I expect ## H... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.